{"pmid":32342541,"title":"Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","text":["Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability.","Head Neck","Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y","32342541"],"abstract":["BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability."],"journal":"Head Neck","authors":["Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342541","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/hed.26206","keywords":["sars-cov2","oncology","otolaryngology"],"topics":["Prevention"],"weight":1,"_version_":1666138495125553152,"score":9.490897,"similar":[{"pmid":32330858,"pmcid":"PMC7136871","title":"Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.","text":["Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.","The COVID-19 pandemic demands reassessment of head and neck oncology treatment paradigms. Head and neck cancer (HNC) patients are generally at high-risk for COVID-19 infection and severe adverse outcomes. Further, there are new, multilevel COVID-19-specific risks to patients, surgeons, health care workers (HCWs), institutions and society. Urgent guidance in the delivery of safe, quality head and neck oncologic care is needed. Novel barriers to safe HNC surgery include: (1) imperfect presurgical screening for COVID-19; (2) prolonged SARS-CoV-2 aerosolization; (3) occurrence of multiple, potentially lengthy, aerosol generating procedures (AGPs) within a single surgery; (4) potential incompatibility of enhanced personal protective equipment (PPE) with routine operative equipment; (5) existential or anticipated PPE shortages. Additionally, novel, COVID-19-specific multilevel risks to HNC patients, HCWs and institutions, and society include: use of immunosuppressive therapy, nosocomial COVID-19 transmission, institutional COVID-19 outbreaks, and, at some locations, societal resource deficiencies requiring health care rationing. Traditional head and neck oncology doctrines require reassessment given the extraordinary COVID-19-specific risks of surgery. Emergent, comprehensive management of these novel, multilevel surgical risks are needed. Until these risks are managed, we temporarily favor nonsurgical therapy over surgery for most mucosal squamous cell carcinomas, wherein surgery and nonsurgical therapy are both first-line options. Where surgery is traditionally preferred, we recommend multidisciplinary evaluation of multilevel surgical-risks, discussion of possible alternative nonsurgical therapies and shared-decision-making with the patient. Where surgery remains indicated, we recommend judicious preoperative planning and development of COVID-19-specific perioperative protocols to maximize the safety and quality of surgical and oncologic care.","Oral Oncol","Day, Andrew T","Sher, David J","Lee, Rebecca C","Truelson, John M","Myers, Larry L","Sumer, Baran D","Stankova, Lenka","Tillman, Brittny N","Hughes, Randall S","Khan, Saad A","Gordin, Eli A","32330858"],"abstract":["The COVID-19 pandemic demands reassessment of head and neck oncology treatment paradigms. Head and neck cancer (HNC) patients are generally at high-risk for COVID-19 infection and severe adverse outcomes. Further, there are new, multilevel COVID-19-specific risks to patients, surgeons, health care workers (HCWs), institutions and society. Urgent guidance in the delivery of safe, quality head and neck oncologic care is needed. Novel barriers to safe HNC surgery include: (1) imperfect presurgical screening for COVID-19; (2) prolonged SARS-CoV-2 aerosolization; (3) occurrence of multiple, potentially lengthy, aerosol generating procedures (AGPs) within a single surgery; (4) potential incompatibility of enhanced personal protective equipment (PPE) with routine operative equipment; (5) existential or anticipated PPE shortages. Additionally, novel, COVID-19-specific multilevel risks to HNC patients, HCWs and institutions, and society include: use of immunosuppressive therapy, nosocomial COVID-19 transmission, institutional COVID-19 outbreaks, and, at some locations, societal resource deficiencies requiring health care rationing. Traditional head and neck oncology doctrines require reassessment given the extraordinary COVID-19-specific risks of surgery. Emergent, comprehensive management of these novel, multilevel surgical risks are needed. Until these risks are managed, we temporarily favor nonsurgical therapy over surgery for most mucosal squamous cell carcinomas, wherein surgery and nonsurgical therapy are both first-line options. Where surgery is traditionally preferred, we recommend multidisciplinary evaluation of multilevel surgical-risks, discussion of possible alternative nonsurgical therapies and shared-decision-making with the patient. Where surgery remains indicated, we recommend judicious preoperative planning and development of COVID-19-specific perioperative protocols to maximize the safety and quality of surgical and oncologic care."],"journal":"Oral Oncol","authors":["Day, Andrew T","Sher, David J","Lee, Rebecca C","Truelson, John M","Myers, Larry L","Sumer, Baran D","Stankova, Lenka","Tillman, Brittny N","Hughes, Randall S","Khan, Saad A","Gordin, Eli A"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330858","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.oraloncology.2020.104684","keywords":["covid-19 pandemic","head and neck cancer","head and neck oncology","mucosal squamous cell carcinoma","multilevel risk","risk stratification","sars-cov-2","surgical barriers","surgical risk","treatment paradigms"],"topics":["Prevention"],"weight":1,"_version_":1666138494701928448,"score":485.6382},{"pmid":32459061,"title":"Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.","text":["Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.","BACKGROUND: The novel coronavirus 2019 (COVID-19) pandemic has changed health care, challenged by resource constraints and fears of transmission. We report the surgical practice pattern changes in a Head and Neck Surgery department of a tertiary cancer care center and discuss the issues surrounding multidisciplinary care during the pandemic. METHODS: We report data regarding outpatient visits, multidisciplinary treatment planning conference, surgical caseload, and modifications of oncologic therapy during this pandemic and compared this data to the same interval last year. RESULTS: We found a 46.7% decrease in outpatient visits and a 46.8% decrease in surgical caseload, compared to 2019. We discuss the factors involved in the decision-making process and perioperative considerations. CONCLUSIONS: Surgical practice patterns in head and neck oncologic surgery will continue to change with the evolving pandemic. Despite constraints, we strive to prioritize and balance the oncologic and safety needs of patients with head and neck cancer in the face of COVID-19.","Head Neck","Kiong, Kimberley L","Guo, Theresa","Yao, Christopher M K L","Gross, Neil D","Hanasono, Matthew M","Ferrarotto, Renata","Rosenthal, David I","Myers, Jeffrey N","Hanna, Ehab Y","Lai, Stephen Y","32459061"],"abstract":["BACKGROUND: The novel coronavirus 2019 (COVID-19) pandemic has changed health care, challenged by resource constraints and fears of transmission. We report the surgical practice pattern changes in a Head and Neck Surgery department of a tertiary cancer care center and discuss the issues surrounding multidisciplinary care during the pandemic. METHODS: We report data regarding outpatient visits, multidisciplinary treatment planning conference, surgical caseload, and modifications of oncologic therapy during this pandemic and compared this data to the same interval last year. RESULTS: We found a 46.7% decrease in outpatient visits and a 46.8% decrease in surgical caseload, compared to 2019. We discuss the factors involved in the decision-making process and perioperative considerations. CONCLUSIONS: Surgical practice patterns in head and neck oncologic surgery will continue to change with the evolving pandemic. Despite constraints, we strive to prioritize and balance the oncologic and safety needs of patients with head and neck cancer in the face of COVID-19."],"journal":"Head Neck","authors":["Kiong, Kimberley L","Guo, Theresa","Yao, Christopher M K L","Gross, Neil D","Hanasono, Matthew M","Ferrarotto, Renata","Rosenthal, David I","Myers, Jeffrey N","Hanna, Ehab Y","Lai, Stephen Y"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32459061","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/hed.26202","keywords":["sars-cov2","oncology","otolaryngology"],"topics":["Prevention"],"weight":1,"_version_":1667967698952257536,"score":455.14194},{"pmid":32437031,"title":"Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines.","text":["Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines.","BACKGROUND: In the face of the COVID-19 pandemic, cancer care has had to adapt rapidly given the Centers for Disease Control and Prevention and the American College of Surgeons (ACS) issuing recommendations to postpone nonurgent surgeries. METHODS: An institutional multidisciplinary group of Head and Neck Surgical Oncology, Surgical Endocrinology, and Medical Endocrinology devised Surgical Triaging Guidelines for Endocrine Surgery during COVID-19, aligned with phases of care published by the ACS. RESULTS: Phases of care with examples of corresponding endocrine cases are outlined. Most cases can be safely postponed with active surveillance, including most differentiated and medullary thyroid cancers. During the most acute phase, all endocrine surgeries are deferred, except thyroid tumors requiring acute airway management. CONCLUSIONS: These guidelines provide context for endocrine surgery within the spectrum of surgical oncology, with the goal of optimal individualized multidisciplinary patient care and the expectation of significant resource diversion to care for patients with COVID-19.","Head Neck","Jozaghi, Yelda","Zafereo, Mark E","Perrier, Nancy D","Wang, Jennifer R","Grubbs, Elizabeth","Gross, Neil D","Fisher, Sarah","Sturgis, Erich M","Goepfert, Ryan P","Lai, Stephen Y","Best, Conor","Busaidy, Naifa L","Cabanillas, Maria E","Dadu, Ramona","Gagel, Robert F","Habra, Mouhammed A","Hu, Mimi I","Jimenez, Camilo","Sherman, Steven I","Thosani, Sonali","Varghese, Jeena","Waguespack, Steven G","Weitzman, Steven","Ying, Anita K","Graham, Paul H","32437031"],"abstract":["BACKGROUND: In the face of the COVID-19 pandemic, cancer care has had to adapt rapidly given the Centers for Disease Control and Prevention and the American College of Surgeons (ACS) issuing recommendations to postpone nonurgent surgeries. METHODS: An institutional multidisciplinary group of Head and Neck Surgical Oncology, Surgical Endocrinology, and Medical Endocrinology devised Surgical Triaging Guidelines for Endocrine Surgery during COVID-19, aligned with phases of care published by the ACS. RESULTS: Phases of care with examples of corresponding endocrine cases are outlined. Most cases can be safely postponed with active surveillance, including most differentiated and medullary thyroid cancers. During the most acute phase, all endocrine surgeries are deferred, except thyroid tumors requiring acute airway management. CONCLUSIONS: These guidelines provide context for endocrine surgery within the spectrum of surgical oncology, with the goal of optimal individualized multidisciplinary patient care and the expectation of significant resource diversion to care for patients with COVID-19."],"journal":"Head Neck","authors":["Jozaghi, Yelda","Zafereo, Mark E","Perrier, Nancy D","Wang, Jennifer R","Grubbs, Elizabeth","Gross, Neil D","Fisher, Sarah","Sturgis, Erich M","Goepfert, Ryan P","Lai, Stephen Y","Best, Conor","Busaidy, Naifa L","Cabanillas, Maria E","Dadu, Ramona","Gagel, Robert F","Habra, Mouhammed A","Hu, Mimi I","Jimenez, Camilo","Sherman, Steven I","Thosani, Sonali","Varghese, Jeena","Waguespack, Steven G","Weitzman, Steven","Ying, Anita K","Graham, Paul H"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437031","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/hed.26169","keywords":["covid","coronavirus","endocrine","guideline","surgery"],"locations":["optimal"],"topics":["Prevention"],"weight":1,"_version_":1667521393616486402,"score":449.0859},{"pmid":32329923,"title":"Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic.","text":["Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic.","BACKGROUND: The SARS-CoV-2 (COVID-19) pandemic has caused rapid changes in head and neck cancer (HNC) care. \"Real-time\" methods to monitor practice patterns can optimize provider safety and patient care. METHODS: Head and neck surgeons from 14 institutions in the United States regularly contributed their practice patterns to a shared spreadsheet. Data from 27 March 2020 to 5 April 2020 was analyzed. RESULTS: All institutions had significantly restricted HNC clinic evaluations. Two institutions stopped free-flap surgery with the remaining scheduling surgery by committee review. Factors contributing to reduced clinical volume included lack of personal protective equipment (PPE) (35%) and lack of rapid COVID-19 testing (86%). CONCLUSIONS: The COVID-19 pandemic has caused a reduction in HNC care. Rapid COVID-19 testing and correlation with infectious potential remain paramount to resuming the care of patients with head and neck cancer. Cloud-based platforms to share practice patterns will be essential as the pandemic evolves.","Head Neck","Patel, Rusha J","Kejner, Alexandra","McMullen, Caitlin","32329923"],"abstract":["BACKGROUND: The SARS-CoV-2 (COVID-19) pandemic has caused rapid changes in head and neck cancer (HNC) care. \"Real-time\" methods to monitor practice patterns can optimize provider safety and patient care. METHODS: Head and neck surgeons from 14 institutions in the United States regularly contributed their practice patterns to a shared spreadsheet. Data from 27 March 2020 to 5 April 2020 was analyzed. RESULTS: All institutions had significantly restricted HNC clinic evaluations. Two institutions stopped free-flap surgery with the remaining scheduling surgery by committee review. Factors contributing to reduced clinical volume included lack of personal protective equipment (PPE) (35%) and lack of rapid COVID-19 testing (86%). CONCLUSIONS: The COVID-19 pandemic has caused a reduction in HNC care. Rapid COVID-19 testing and correlation with infectious potential remain paramount to resuming the care of patients with head and neck cancer. Cloud-based platforms to share practice patterns will be essential as the pandemic evolves."],"journal":"Head Neck","authors":["Patel, Rusha J","Kejner, Alexandra","McMullen, Caitlin"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329923","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/hed.26189","keywords":["covid-19 pandemic","head and neck cancer treatment","head and neck surgery","microvascular reconstruction","practice patterns"],"locations":["United States","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138494693539843,"score":375.09708},{"pmid":32338298,"title":"The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic.","text":["The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic.","The coronavirus disease 2019 pandemic has resulted in new challenges for clinicians, head and neck cancer (HNC) patients and carers. There is evidence that the current crisis is affecting the management of HNC patients. Most healthcare systems have introduced remote consultations to decrease the risk of coronavirus infection to patients, carers and clinicians. At present, HNC patients may be anxious and due to logistical issues, may not be adequately prepared for their treatment. To ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 crisis there may be merit in the use of the HaNC-AD PCI.","Eur Arch Otorhinolaryngol","Kanatas, Anastasios","Rogers, S N","32338298"],"abstract":["The coronavirus disease 2019 pandemic has resulted in new challenges for clinicians, head and neck cancer (HNC) patients and carers. There is evidence that the current crisis is affecting the management of HNC patients. Most healthcare systems have introduced remote consultations to decrease the risk of coronavirus infection to patients, carers and clinicians. At present, HNC patients may be anxious and due to logistical issues, may not be adequately prepared for their treatment. To ensure that patients have a thorough understanding of their treatment and expected outcome during the current COVID-19 crisis there may be merit in the use of the HaNC-AD PCI."],"journal":"Eur Arch Otorhinolaryngol","authors":["Kanatas, Anastasios","Rogers, S N"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32338298","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1007/s00405-020-05995-9","keywords":["coronavirus","head and neck cancer","patient concerns inventory","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1666138494236360704,"score":374.65646}]}